mintreleq xl 50mg tablets
aristo pharma ltd - quetiapine fumarate - modified-release tablet - 50mg
mintreleq xl 150mg tablets
aristo pharma ltd - quetiapine fumarate - modified-release tablet - 150mg
mintreleq xl 200mg tablets
aristo pharma ltd - quetiapine fumarate - modified-release tablet - 200mg
mintreleq xl 300mg tablets
aristo pharma ltd - quetiapine fumarate - modified-release tablet - 300mg
mintreleq xl 400mg tablets
aristo pharma ltd - quetiapine fumarate - modified-release tablet - 400mg
myclausen
passauer pharma gmbh - mycophenolate mofetil - graft rejection - immunosuppressants - myclausen is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.,
ondansetron 4mg orodispersible tablets
aristo pharma ltd - ondansetron - orodispersible tablet - 4mg
ondansetron 8mg orodispersible tablets
aristo pharma ltd - ondansetron - orodispersible tablet - 8mg
tibolone 2.5mg tablets
aristo pharma ltd - tibolone - oral tablet - 2.5mg
aristopet animal health fly repellent for dogs
qpharma pty ltd - n-octyl bicycloheptene dicarboximide; di-n-propyl isocinchomeronate; piperonyl butoxide; diethyltoluamide; citronella oil; pyrethrins - topical aerosol spray - n-octyl bicycloheptene dicarboximide bicyclo active 13.0 g/l; di-n-propyl isocinchomeronate benzene active 17.0 g/l; piperonyl butoxide benzodioxole active 8.0 g/l; diethyltoluamide insect repellent active 17.0 g/l; citronella oil oil-plant extract active 5.0 g/l; pyrethrins pyrethroid-pyrethrin active 2.0 g/l - parasiticides